Clinical Trial Update: Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating dihydrotestosterone-regulated gene expression in benign prostatic hyperplasia and prostate cancer. The study status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostate Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia, Prostate Cancer | Phase 4 | Status: COMPLETED